Health-service use in women with binge eating disorders

About this resource

Objective: To compare health-care utilization between participants who met DSM-IV criteria for binge eating disorder (BED) and those engaged in recurrent binge eating (RBE) and to evaluate whether objective binge eating (OBE) days, a key measurement for diagnosing BED, predicted health-care costs. Method: We obtained utilization and cost data from electronic medical records to augment patient reported data for 100 adult female members of a large health maintenance organization who were enrolled in a randomized clinical trial to treat binge eating. Results: Total costs did not differ between the BED and RBE groups ($\beta$ = ˆ’0.117, z = ˆ’0.48, p = .629), nor did the number of OBE days predict total costs ($\beta$ = ˆ’0.017, z = ˆ’1.01, p = .313). Discussion: Findings suggest that the medical impairment, as assessed through health care costs, caused by BED may not be greater than impairment caused by RBE. The current threshold number of two OBE days/week as a criterion for BED may need to be reconsidered. (c) 2010 by Wiley Periodicals, Inc. Int J Eat Disord 2011

AuthorDickerson, John F.; Debar, Lynn; Perrin, Nancy a.; Lynch, Frances; Wilson, G. Terence; Rosselli, Francine; Kraemer, Helena C. & Striegel-Moore, Ruth H.
JournalInternational Journal of Eating Disorders

See also

A comprehensive meta-analysis of the risk of suicide in eating disorders

OBJECTIVE: Past meta-analyses on suicide in eating disorders included few available studies.

Read more

Olanzapine in the treatment of low body weight and obsessive thinking in women with anorexia nervosa: A randomized, double-blind, placebo-controlled trial

OBJECTIVE: Anorexia nervosa is associated with high mortality, morbidity, and treatment costs.

Read more

Rapid response predicts treatment outcomes in binge eating disorder: Implications for stepped care

The authors examined rapid response in 75 overweight patients with binge eating disorder (BED) who participated in a randomized clinical trial of guided self-help treatments (cognitive-behavioral therapy [CBTgsh] and behavioral weight loss [BWLgsh]).

Read more

Lisdexamfetamine for binge eating disorder in adults: A systematic review of the efficacy and safety profile for this newly approved indication - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?

OBJECTIVE: To describe the efficacy and safety of lisdexamfetamine dimesylate (LDX) for the treatment of binge eating disorder (BED).

Read more

Help us improve!

Give us feedback!

We will continue throughout 2019 to update and improve the NEDC website and welcome any feedback you may have on the site.

Provide feedback